Hearing (law)

Cullinan Properties recognized with CoStar Impact Award for Veterans' Clinic

Retrieved on: 
Wednesday, April 3, 2024
Hearing (law), IRS, Trade, General Services Administration, Health, Veterans' affairs, Federation, CoStar Group, History, GSA, OSHA, SF, FBI, Property

EAST PEORIA, Ill., April 3, 2024 /PRNewswire-PRWeb/ -- The 150,000 SF project began construction in 2021 and opened in December 2023 in Temple Terrace, Florida. Multiple mental health programs were consolidated into this state-of-the-art center to meet the healthcare needs of Veterans.

Key Points: 
  • Cullinan Properties has been named the 2024 Commercial Development CoStar Impact Award winner for the James A. Haley Veterans Affairs Mental Health Center in the Tampa/St.
  • "Through dedication, innovative solutions, and relentless determination, we've constructed more than just a building; we've built a haven for our veterans," said Michael Gold, President, Cullinan Properties.
  • The Cullinan Team honors veterans by delivering more than structures—we deliver hope, healing, and gratitude," said Michael Gold, President, Cullinan Properties.
  • To learn more about the CoStar Impact Awards and review the full list of winners, visit www.CoStarImpactAwards.com/ .

GRAND CANYON UNIVERSITY APPEALS UNPRECEDENTED DECISION, RECORD FINE FROM U.S. DEPARTMENT OF EDUCATION

Retrieved on: 
Thursday, November 16, 2023
HLC, Eye, Disclosure, Behavior, Higher, Christian college, Grand Canyon University, Federation, DPC, Student, The Department, Hearing (law), Ivy League, University, Higher Learning Commission, Parent, Government, GCU, Management, Nursing, Education

PHOENIX, Nov. 16, 2023 /PRNewswire/ -- Grand Canyon University has sent a notification to the U.S. Department of Education that it is appealing the unprecedented and unjust $37.7 million fine levied against the university and has vowed to stand up to the federal government's broader efforts to target the largest Christian university in the country.

Key Points: 
  • PHOENIX, Nov. 16, 2023 /PRNewswire/ -- Grand Canyon University has sent a notification to the U.S. Department of Education that it is appealing the unprecedented and unjust $37.7 million fine levied against the university and has vowed to stand up to the federal government's broader efforts to target the largest Christian university in the country.
  • Rather than applaud such efforts or work cooperatively with GCU in a matter that could easily be resolved in a 10-minute phone call, the Department has instead chosen to impose a record fine, which speaks to their agenda and motivations."
  • In Young v GCU, the courts rejected the claim that GCU's disclosures misrepresented the time or cost to complete a doctoral program.
  • All of those appeal opportunities fall within the Department of Education, first with the Department's Office of Hearings and Appeals, and then to the Department's Secretary of Education.

Mullen Automotive Starts Stock Buyback Program

Retrieved on: 
Thursday, August 17, 2023
Maker, EV, OTC Bulletin Board, Mullen Technologies, Mister Maker, Share repurchase, IBN, Hearing (law), Security (finance), Market maker, Auction

(NASDAQ: MULN ) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces the start of the Company’s $25 million stock buyback program with the repurchase of 3.7 million shares of common stock, which started on Aug. 16, 2023, and can continue through Dec. 31, 2023, for an aggregate of $3,626,000.

Key Points: 
  • (NASDAQ: MULN ) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces the start of the Company’s $25 million stock buyback program with the repurchase of 3.7 million shares of common stock, which started on Aug. 16, 2023, and can continue through Dec. 31, 2023, for an aggregate of $3,626,000.
  • On July 6, 2023, the Board of Directors (the "Board") of the Company authorized a stock buyback program, pursuant to which the Company may, until Dec. 31, 2023, purchase up to $25 million in shares of its outstanding common stock.
  • The authorization of the stock buyback program does not obligate the Company to purchase any shares and may be terminated or amended by the Board at any time prior to its expiration date.
  • For more information on Mullen Automotive or SEC public filings, please visit the investor relations section of Mullen’s website or SEC.gov .

Yandex announces favorable decision of Nasdaq Listing Hearings Panel

Retrieved on: 
Saturday, June 10, 2023
Acquisition, Hearing, Hearing (law), Moscow Exchange, Staff, Security (finance), Cryptocurrency, Yandex

Amsterdam, June 8, 2023 – As previously disclosed, on March 15, 2023, Yandex N.V. (“Yandex”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined that the Company’s Class A ordinary shares would be delisted from The Nasdaq Stock Market.

Key Points: 
  • Amsterdam, June 8, 2023 – As previously disclosed, on March 15, 2023, Yandex N.V. (“Yandex”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined that the Company’s Class A ordinary shares would be delisted from The Nasdaq Stock Market.
  • On April 27, 2023, a hearing was held before the Nasdaq Hearings Panel in connection with Yandex’s appeal of the Staff’s determination.
  • On June 6, 2023, Yandex received notification of the Hearings Panel’s decision to grant the request of Yandex to continue its listing on Nasdaq, subject to certain conditions related to the timing and implementation of Yandex’s proposed corporate restructuring, including the divestment of ownership and control of a number of our core businesses, including all Russia-based businesses, by the end of 2023.
  • The trading of Yandex N.V.’s Class A shares on the Moscow Exchange is unaffected and continues as usual.

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

Retrieved on: 
Monday, December 19, 2022
General counsel, RMB, CDA, Human, Court, Staff, CPP Investment Board, Plaintiff, Research, AACR, Lung cancer, ASU, Failure, COVID-19, Acquisition, Hospital, Prognosis, Patent, Calendar, Hearing (law), ADS, Action, Public expenditure, Trial of the century, Delaware Court, Diagnosis, Marketing, Harvey, Animal, Generic drug, Security (finance), Bank, Pharmaceutical industry

● Net loss was approximately RMB48.8 million (US$7.3 million) for the six months ended June 30, 2022, compared to a net loss of approximately RMB57.7 million for the same period of 2021, 15.4% decrease from the same period in 2021.

Key Points: 
  • ● Net loss was approximately RMB48.8 million (US$7.3 million) for the six months ended June 30, 2022, compared to a net loss of approximately RMB57.7 million for the same period of 2021, 15.4% decrease from the same period in 2021.
  • ● Non-GAAP net loss¹ was approximately RMB44.4 million (US$6.6 million) for the six months ended June 30, 2022, compared to a non-GAAP net loss of approximately RMB37.4 million for the same period of 2021.
  • (1) Non-GAAP net loss is defined as net loss excluding change in fair value of convertible debts and share-based compensation.
  • The Company also issued 6,000,000 shares as reserve for potential convertible loans conversion in the first quarter of 2022.

Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing

Retrieved on: 
Tuesday, December 20, 2022
Biotechnology, Pharmaceutical, Health, Neurology, ACOR, Hearing (law), Calendar, Panel, Therapy, Acorda Therapeutics, Hearing

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it was notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC that, due to the Company's common stock not having regained compliance with the minimum price of $1.00, the stock is subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel.

Key Points: 
  • Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it was notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC that, due to the Company's common stock not having regained compliance with the minimum price of $1.00, the stock is subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel.
  • The Company plans to submit such request within the required seven calendar days, which will stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Hearings Panel following the hearing.
  • The Hearings Panel has the discretion to grant the Company an extension through June 17, 2023.
  • At the hearing, the Company intends to present a plan to achieve compliance with the Nasdaq listing requirements and to request additional time to regain such compliance.

AnPac Announces Regaining Compliance with Nasdaq Listing Requirement

Retrieved on: 
Wednesday, November 30, 2022
General counsel, Hellenic Capital Market Commission, Laboratory, Listing Rules, Risk, Frost, Annual report, Staff, CLIA, Letter, Hearing (law), Calendar, Research, Failure, Hearing, CDA, Coronavirus, Capital market, NMPA, CAP, FDA, Risk management

On June 9, 2022, AnPac Bio-Medical Science Co., Ltd. (the Company) received the determination from The Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the requirements to remain listed in The Nasdaq Capital Market subject to a one-year Mandatory Panel Monitor of the Companys ongoing compliance with such requirements as set force in Listing Rule 5815(d)(4)(B).

Key Points: 
  • On June 9, 2022, AnPac Bio-Medical Science Co., Ltd. (the Company) received the determination from The Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the requirements to remain listed in The Nasdaq Capital Market subject to a one-year Mandatory Panel Monitor of the Companys ongoing compliance with such requirements as set force in Listing Rule 5815(d)(4)(B).
  • The Company will have the opportunity to respond/present to the Hearings Panel as provided by Listing Rule 5815(d)(4)(C).
  • This request was due to a Staff determination letter (the Letter) on September9, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) notifying the Company of the Staffs determination to delist the Companys securities from The Nasdaq Capital Market due to the Companys failure to regain compliance with the $1 per share bid price requirement of Listed Securities required for continued listing as set forth in Listing Rule5450(a)(1)(the $1 Bid Rule), following the 180 calendar day compliance period set forth in Listing Rule5810(c)(3)(A)(the Compliance Period).
  • On September16, 2022, Company received a letter from Nasdaq granting the appeal and scheduling the Nasdaq Hearings Panel for October20, 2022.

ClearanceJobs Connect 2022 Brings Together Talent Acquisition and HR Professionals in the National Security Space

Retrieved on: 
Wednesday, October 12, 2022
Public Policy, Government, Software, White House, Federal Government, Human Resources, Artificial Intelligence, Professional Services, Technology, Homeland Security, Paragon, DHI (company), Dice, DHX, Security agency, National Science and Technology Council, NYSE, Intelligence, National, DCSA, Workforce, Open Source Security Foundation, National Counterintelligence and Security Center, Connect, Senior, Technology, Dice.com, Software, Company, Learning, Industry, Board, Paragon Systems, DHI, Defense Counterintelligence and Security Agency, Hearing (law), Security, Federation, Trustee, ClearanceJobs, Defense, Mobile phone, Risk management, Public relations

ClearanceJobs, a DHI Group, Inc. (NYSE: DHX) brand, hosted over 200 attendees in the security cleared recruiting community for ClearanceJobs Connect 2022.

Key Points: 
  • ClearanceJobs, a DHI Group, Inc. (NYSE: DHX) brand, hosted over 200 attendees in the security cleared recruiting community for ClearanceJobs Connect 2022.
  • Sponsors including SIMS Software, GDIT, Paragon Systems, and the Northern Virginia Technology Council supported this gathering of national security and intelligence community hiring and security leaders.
  • The packed schedule also featured innovative cleared recruiting ideas shared by thought leaders in the national security community and defense industry.
  • All Registered Users of ClearanceJobs Must be U.S. Citizens
    Founded in 2002, ClearanceJobs is a modern marketplace for career opportunities in national security.

Aquia Inc. Wins Subcontract from Coforma to Develop Centers for Medicare & Medicaid Services (CMS) Complaint Submission Portal

Retrieved on: 
Thursday, September 1, 2022
Centers for Medicare & Medicaid Services, MVP, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Human services, DE, CMS, DNA, Provisions of the Affordable Care Act, Public sector, Center, Medicare, Federation, Hearing (law), MBR, Care Act 2014, Aquia, Legislation, Real estate, Health insurance

BALTIMORE, Aug. 31, 2022 /PRNewswire/ -- Aquia Inc., a Service-Disabled Veteran-Owned Small Business specializing in cloud and cybersecurity professional services, today announced that it has been awarded a subcontract from Coforma to support its one-year, $4 million contract with the Centers for Medicare and Medicaid Services (CMS).

Key Points: 
  • Under the contract, Coforma will develop a digital minimum viable product (MVP) to facilitate patient-provider dispute resolution, including the front-end complaint submission portal and all of the back-end workflows supporting the tracking and resolution of action.
  • Coforma is the perfect team to get this next level of maturity off the ground."
  • Aquia Inc. is a Service-Disabled Veteran-Owned Small Business based in Millsboro, DE.
  • At Aquia, we value trust, accountability, transparency, and diversity; and we've built these tenants into the DNA of our company.